Verona Pharma 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?

최근 내부자 거래

NasdaqGM:VRNA 회사 또는 개인의 최근 내부자 거래
날짜	가치	이름	엔티티	공유	최대 가격
18 Nov 24	BuyUS$33,300	David Ebsworth	Individual	2,500	US$13.32
11 Nov 24	SellUS$12,000	Mark Hahn	Individual	300	US$40.00
11 Nov 24	SellUS$12,000	David Zaccardelli	Individual	300	US$40.00
06 Nov 24	BuyUS$198,386	Christina Ackermann	Individual	5,235	US$37.90
06 Nov 24	BuyUS$188,881	David Ebsworth	Individual	4,920	US$38.39
04 Nov 24	SellUS$568,387	Mark Hahn	Individual	16,209	US$35.10
04 Nov 24	SellUS$618,658	David Zaccardelli	Individual	17,629	US$35.13
25 Oct 24	SellUS$633,896	David Zaccardelli	Individual	18,102	US$35.02
25 Oct 24	SellUS$632,761	Mark Hahn	Individual	18,070	US$35.02
22 Oct 24	SellUS$2,303,773	Mark Hahn	Individual	525,768	US$4.38
22 Oct 24	SellUS$2,253,237	David Zaccardelli	Individual	514,152	US$4.39
11 Sep 24	SellUS$2,254,080	Mark Hahn	Individual	600,000	US$3.76
11 Sep 24	SellUS$2,254,320	David Zaccardelli	Individual	600,000	US$3.76
13 Aug 24	SellUS$1,275,540	Mark Hahn	Individual	49,800	US$26.00
12 Aug 24	BuyUS$103,320	David Ebsworth	Individual	4,500	US$22.96
12 Aug 24	SellUS$5,008	Mark Hahn	Individual	200	US$25.04
12 Aug 24	SellUS$5,008	David Zaccardelli	Individual	200	US$25.04

내부자 거래량

내부자 구매: VRNA insiders는 지난 3개월 동안 구매한 것보다 더 많은 주식을 판매했습니다.

소유권 분석

VRNA 의 소유 구조는 어떻게 되나요?
소유자 유형	공유 수	소유권 비율
일반 대중	2,424,165	2.96%
개인 내부자	3,660,371	4.47%
헤지 펀드	4,215,973	5.15%
VC/PE 기업	18,096,325	22.1%
교육기관	53,434,335	65.3%

주식의 희석: 지난 해 주주들은 의미 있게 희석되지 않았습니다.

최대 주주

상위 25 주주가 회사의 74.81%를 소유하고 있습니다.

소유권	이름	공유	현재 값	변경 %	포트폴리오 %
7.72%	Perceptive Advisors LLC	6,315,933	US$240.6m	160%	4.93%
7.57%	RA Capital Management, L.P.	6,195,639	US$236.0m	-29.7%	2.72%
6.82%	New Enterprise Associates, Inc.	5,584,753	US$212.7m	0%	9.11%
5.15%	Maverick Capital, Ltd.	4,215,973	US$160.6m	36.3%	2.78%
4.62%	OrbiMed Advisors LLC	3,777,778	US$143.9m	0%	1.88%
4.34%	Vivo Capital, LLC	3,549,779	US$135.2m	-46.3%	10.76%
4.14%	Frazier Life Sciences Management, LP	3,383,950	US$128.9m	2.1%	4.86%
3.89%	Deep Track Capital, LP	3,180,025	US$121.1m	-20.5%	3.52%
2.96%	Eventide Asset Management, LLC	2,425,846	US$92.4m	360%	1.51%
2.65%	Federated Hermes, Inc.	2,167,900	US$82.6m	0.2%	0.19%
2.3%	Wellington Management Group LLP	1,878,632	US$71.6m	19.6%	0.01%
2.24%	Octagon Capital Advisors LP	1,835,200	US$69.9m	-3.17%	10.86%
2.13%	Jennison Associates LLC	1,740,886	US$66.3m	54.3%	0.04%
1.86%	David Zaccardelli	1,525,294	US$58.1m	-1.8%	데이터 없음
1.76%	Caligan Partners, LP	1,436,878	US$54.7m	-22.1%	16.15%
1.75%	Hood River Capital Management LLC	1,433,934	US$54.6m	35%	0.78%
1.72%	Mark Hahn	1,411,417	US$53.8m	-1.94%	데이터 없음
1.63%	T. Rowe Price Group, Inc.	1,335,194	US$50.9m	40.6%	데이터 없음
1.49%	Bellevue Asset Management AG	1,220,059	US$46.5m	7.57%	0.52%
1.44%	Citadel Advisors LLC	1,178,022	US$44.9m	1,050%	0.05%
1.43%	Federated Equity Management Company of Pennsylvania	1,173,600	US$44.7m	0%	0.23%
1.36%	Aisling Capital Management LP	1,115,352	US$42.5m	0%	15.85%
1.36%	Loomis Sayles & Company, L.P.	1,111,096	US$42.3m	0%	0.05%
1.27%	Janus Henderson Group plc	1,042,795	US$39.7m	-4.51%	0.01%
1.2%	Rice Hall James & Associates, LLC	985,076	US$37.5m	4.84%	1.9%